194 related articles for article (PubMed ID: 11729198)
1. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation.
Voziyan PA; Metz TO; Baynes JW; Hudson BG
J Biol Chem; 2002 Feb; 277(5):3397-403. PubMed ID: 11729198
[TBL] [Abstract][Full Text] [Related]
2. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine.
Onorato JM; Jenkins AJ; Thorpe SR; Baynes JW
J Biol Chem; 2000 Jul; 275(28):21177-84. PubMed ID: 10801874
[TBL] [Abstract][Full Text] [Related]
3. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications.
Metz TO; Alderson NL; Thorpe SR; Baynes JW
Arch Biochem Biophys; 2003 Nov; 419(1):41-9. PubMed ID: 14568007
[TBL] [Abstract][Full Text] [Related]
4. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
[TBL] [Abstract][Full Text] [Related]
5. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.
Voziyan PA; Khalifah RG; Thibaudeau C; Yildiz A; Jacob J; Serianni AS; Hudson BG
J Biol Chem; 2003 Nov; 278(47):46616-24. PubMed ID: 12975371
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction.
Glomb MA; Monnier VM
J Biol Chem; 1995 Apr; 270(17):10017-26. PubMed ID: 7730303
[TBL] [Abstract][Full Text] [Related]
7. Reaction of pyridoxamine with malondialdehyde: mechanism of inhibition of formation of advanced lipoxidation end-products.
Kang Z; Li H; Li G; Yin D
Amino Acids; 2006 Feb; 30(1):55-61. PubMed ID: 15990947
[TBL] [Abstract][Full Text] [Related]
8. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
Booth AA; Khalifah RG; Todd P; Hudson BG
J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
[TBL] [Abstract][Full Text] [Related]
9. Propagation of protein glycation damage involves modification of tryptophan residues via reactive oxygen species: inhibition by pyridoxamine.
Chetyrkin SV; Mathis ME; Ham AJ; Hachey DL; Hudson BG; Voziyan PA
Free Radic Biol Med; 2008 Apr; 44(7):1276-85. PubMed ID: 18374270
[TBL] [Abstract][Full Text] [Related]
10. Pyridoxamine traps intermediates in lipid peroxidation reactions in vivo: evidence on the role of lipids in chemical modification of protein and development of diabetic complications.
Metz TO; Alderson NL; Chachich ME; Thorpe SR; Baynes JW
J Biol Chem; 2003 Oct; 278(43):42012-9. PubMed ID: 12923193
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.
Ahmad S; Shahab U; Baig MH; Khan MS; Khan MS; Srivastava AK; Saeed M; Moinuddin
PLoS One; 2013; 8(9):e72128. PubMed ID: 24023728
[TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of the site specificity of glycation and carboxymethylation of ribonuclease.
Brock JW; Hinton DJ; Cotham WE; Metz TO; Thorpe SR; Baynes JW; Ames JM
J Proteome Res; 2003; 2(5):506-13. PubMed ID: 14582647
[TBL] [Abstract][Full Text] [Related]
13. Paradoxical impact of antioxidants on post-Amadori glycoxidation: Counterintuitive increase in the yields of pentosidine and Nepsilon-carboxymethyllysine using a novel multifunctional pyridoxamine derivative.
Culbertson SM; Vassilenko EI; Morrison LD; Ingold KU
J Biol Chem; 2003 Oct; 278(40):38384-94. PubMed ID: 12878609
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of the inhibitory effect of OPB-9195 [(+/-)-2-isopropylidenehydrazono-4-oxo-thiazolidin-5-yla cetanilide] on advanced glycation end product and advanced lipoxidation end product formation.
Miyata T; Ueda Y; Asahi K; Izuhara Y; Inagi R; Saito A; VAN Ypersele DE Strihou C; Kurokawa K
J Am Soc Nephrol; 2000 Sep; 11(9):1719-1725. PubMed ID: 10966497
[TBL] [Abstract][Full Text] [Related]
15. Transketolase A from E. coli Significantly Suppresses Protein Glycation by Glycolaldehyde and Glyoxal in Vitro.
Klaus A; Pfirrmann T; Glomb MA
J Agric Food Chem; 2017 Sep; 65(37):8196-8202. PubMed ID: 28880548
[TBL] [Abstract][Full Text] [Related]
16. Chelating activity of advanced glycation end-product inhibitors.
Price DL; Rhett PM; Thorpe SR; Baynes JW
J Biol Chem; 2001 Dec; 276(52):48967-72. PubMed ID: 11677237
[TBL] [Abstract][Full Text] [Related]
17. Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor.
Nagai R; Matsumoto K; Ling X; Suzuki H; Araki T; Horiuchi S
Diabetes; 2000 Oct; 49(10):1714-23. PubMed ID: 11016456
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.
Valencia JV; Weldon SC; Quinn D; Kiers GH; DeGroot J; TeKoppele JM; Hughes TE
Anal Biochem; 2004 Jan; 324(1):68-78. PubMed ID: 14654047
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a novel radical trapping and carbonyl group trapping anti-AGE agent: a pyridoxamine analogue for inhibiting advanced glycation (AGE) and lipoxidation (ALE) end products.
Culbertson SM; Enright GD; Ingold KU
Org Lett; 2003 Jul; 5(15):2659-62. PubMed ID: 12868883
[TBL] [Abstract][Full Text] [Related]
20. The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats.
Alderson NL; Chachich ME; Youssef NN; Beattie RJ; Nachtigal M; Thorpe SR; Baynes JW
Kidney Int; 2003 Jun; 63(6):2123-33. PubMed ID: 12753299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]